Official press releases from Edwards Lifesciences or Becton Dickinson, financial news reports

Edwards Lifesciences to Sell Critical Care Unit to Becton Dickinson for $4.2 Billion in Cash

Jun 3, 2024, 12:26 PM

Edwards Lifesciences has agreed to sell its critical care products unit to Becton Dickinson for $4.2 billion in an all-cash transaction. The move is aimed at allowing Edwards Lifesciences to focus more on its heart devices business. Becton Dickinson, also known as BD, plans to expand its portfolio of smart medical monitoring and patient monitoring products through this acquisition. The deal was announced on Monday, June 3, 2024, and has positively impacted the stock prices of both companies, with BDX up 2.2% and EW up 3.6% in pre-market trading.